Health care law is totally localized in its nature, but research for the development of new drugs has crossed man-made geographical limits. Weaker legal sanctions, poverty, illiteracy and inaccessibility to legal system have all contributed to make India a favored hub for contact research organizations. Many recent clinical drug trials in India have sparked controversy. However, in India today, we are more bothered about animal protection, but show little concern for volunteers in human trials. It is gradually becoming difficult to conduct research on animals; however, research on human beings is far easier. Sanctions against violation of rights of human volunteers in clinical trials are often only a perceived phenomenon. They are not protected as they should be. Regulatory framework needs thorough introspection, debate, reconsideration and strict implementation. These guidelines should not only be recommendatory but mandatory in nature and those who indulge in violations, shall be punished as per the law of the land effectively.
INTRODUCTION
Clinical research is mandatory to find out the new treatments for the diseases of the modern world with a binding that research would take care about the ethical component and rationality in a civilized world on civilized society in a civilized manner. Health care law is totally localized in its nature, but research for the development of new drugs has crossed man-made geographical limits. 1 The developing nations have become a soft target, where despite efforts only few new molecules of drugs are found; hence, such nations have become a hub of contract research organizations (CROs). 2 In case of any adverse event during a trial, it is becoming increasingly difficult to hold such international companies which are getting their trials done through CROs of the developing nations accountable and liable. If such clinical trials on human subjects fall under the ambit of 'fiduciary relationship', then why as per the Law of Tort it is not amounting to negligence, in case of serious consequences related to subjects of the drug trials?
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Moreover, the liabilities of drug companies also arise, when we apply the principle of 'vicarious liability'. As per general principles of law and rules of natural justice, human being is conferred with certain basic human rights which are reaffirmed under tenets of Universal Human Rights, 1948. The conduct of clinical trials without informed consent on the prisoners of war in Second World War by Germans led to the birth of Nuremberg Code in 1947 whereby it was declared inhuman to try newer drugs on prisoners of war.
3 Importance of consent was recognized which was later reflected in subsequent declarations of Helsinki, to which whole world agreed in principles under various treaties of Public International Law. 4 Whenever human subjects are enrolled in a clinical drug trial, a fiduciary relationship arises among the researchers and the volunteers, giving rise to rights and duties. So, whenever there is breach of duties, it will automatically become the basis of right to claim compensation under tort of negligence. Hence, whenever there is breach of duty on part of researcher, volunteer can make him liable or through him, drug company can be made vicariously liable. Thereby, duty, breach of duty on part of researcher(s), damages to volunteer's interest and compensation in lieu of the damages are all components of Law of Tort. Hence, even the provisions of company laws need to be amended to safeguard the interests of such volunteers who are largely poor, illiterate and ignorant of their fundamental rights in India.
When the consent is taken from volunteer of clinical trial for the participation with the promise that such individual will get drug supply uninterrupted even once the trial is over; the inability of providing that drug to such individual is violation of 'promissory estoppels' under section 115 Indian Evidence Act 1872. Whatever is promised must be fulfilled subsequently.
WHY THESE SITUATIONS ARE COMING TO FOREFRONT?
The 
GUIDELINES FOR HUMAN TRIALS LACKING THE CANINES
However, the ICMR guidelines have weak legal sanctions. According to Dr VM Katoch, Director General, ICMR, low costs, weak laws and inadequate enforcement and penalties can be blamed for the present state of affairs. 21 The ethics committees are improperly constituted, privately managed, decentralized and have researchers of these trials as their members thereby generating conflict of interest. Though, the Clinical Trials Registry-India (CTRI), a welcomed initiative by ICMR, has been made mandatory with effect from 15th June 2009 22 lack of central registry of ethical committees allows numerous unethical trials rejected by IRBs to get accepted by other private ethics committees. Many a times, the so called 'healthy' volunteers recruited by CROs in various trials fail to be so and suffer adverse outcome. There is no provision as to who declares them to be 'healthy' prior to recruitment. An infant in Bangalore, who had a pre-existing cardiac disorder, died during a Wyeth sponsored clinical trial for an advanced pneumonia vaccine. 23 According to Drugs Controller General India (DCGI), the 'inclusion-exclusion' criteria protocol was not adhered to by the investigator. Participation of a volunteer in multiple clinical trials without mandatory 3 months washoff period is not uncommon practice. There is no independent review board to conduct enquiry in case of any adverse events during such trials, which is left all to the discretion of the sponsoring multinational company. Furthermore, the amount of compensation is not fixed nor it is applicable to private doctors conducting clinical trials. Though there has been tremendous increase in number of CROs in India, no rules and regulations have been framed to keep them under scrutiny. These agencies shove off any responsibility if any untoward event occurs during trials. There is no grievance reprisal forum for victims of these trials and vast majority of illiterate, ignorant and poor citizens of India are unaware of whom to contact in case of any complaints: The treating physician cum researcher/ institute head/CRO/sponsoring multinational company/ marketing company/NHRC/DCGI or the media. However, in India today, we are more bothered about animal protection but show little concern for volunteers in human trials. It is gradually becoming difficult to conduct research on animals; however, research on human beings is far easier. Though such volunteers of clinical drug trials are considered as guinea pigs (despite equating them to animals, they are not protected like the animals), thanks to Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA) and People for the Ethical Treatment of Animals (PETA) for their continuous pressure and pursuance in implementing the legal sanctions against erring individuals/agencies through court of law.
The Animal Welfare Act 2011 clearly states that (a) contravention of section 21 or any order made by Committee under section 27 or (b) commitment of breach of any requirement/condition imposed by the committee under those sections shall be punishable with fine not less than ` 20,000/-and may extend to ` 50,000/-or imprisonment which shall not be less than 1 year but may extend to 3 years or with both. In case of second and subsequent offence, fine of ` 75,000/-and may extend to 1 Lac and imprisonment not less than 2 years which may extend to 5 years. If such breach occurs within an institution, the person in charge of such an institute shall also be deemed to be jointly guilty of the offence and punished according to the Act. If there is need to enhance the penalties prescribed, Government can do so by notification in the official gazette. However, according to the news item from Times of India July 3, 2011, the offender could end up paying up to ` 1 crore fine or be jailed for 5 years as proposed by Environment and Forests ministry in Animal Welfare Bill 2011. For institutions or companies, the penalty could be even ` 25 crores. 24 However, sanctions against violation of rights of human volunteers in clinical trials are often only a perceived phenomenon. They are not protected as they should be. Government shall enact the law on similar lines so that these guinea pigs of clinical trials are protected and safeguarded. Regulatory framework needs thorough introspection, debate, reconsideration and strict implementation. These guidelines should not only be recommendatory but mandatory in nature and those who indulge in violations, shall be punished as per the law of the land effectively.
